PI
HALO icon

Pathlight Investors’s Halozyme HALO Stock Holding History

Pathlight Investors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$151K Buy
+10,000
New +$160K 0.12% 102

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Pathlight Investors's HALO Position: Q4 2018 in Review

Pathlight Investors opened a new position in Halozyme (HALO) in Q4 2018: 10,000 shares worth $151K. The stake represents 0.12% of the portfolio and ranks #102 among its holdings.

195 funds tracked by Wall St. Rank hold HALO as of Q4 2018.

  • Pathlight Investors held 10,000 shares of Halozyme worth $151K as of Q4 2018.
  • Halozyme was a new Pathlight Investors position in Q4 2018.
  • Halozyme made up 0.12% of Pathlight Investors's portfolio in Q4 2018, its #102 holding.
  • 195 funds tracked by Wall St. Rank held Halozyme as of Q4 2018.

Based on Pathlight Investors's 13F filing for Q4 2018, filed 19 Feb 2019.